This trial is active, not recruiting.

Condition chronic stable angina
Treatment psychoeducation
Phase phase 1
Sponsor University of Toronto
Start date September 2003
End date November 2005
Trial size 130 participants
Trial identifier NCT00350922, 452639


The purpose of this clinical trial was to determine the effectiveness of a supportive and educational self-management program for improving health-related quality of life (HRQOL), angina symptoms, and self-efficacy and resourcefulness to self-manage for chronic angina patients. 130 participants were enrolled in the trial for 3 months. The program, entitled the Chronic Angina Self-Management Program, (CASMP) was found effective for improving HRQOL, angina symptoms, and self-efficacy to manage symptoms, compared to usual care.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose treatment

Primary Outcomes

time frame:
Seattle Angina Questionnaire
time frame:

Secondary Outcomes

Self-Efficacy Scale
time frame:
Self-Control Schedule
time frame:

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: Medical diagnosis of coronary artery disease CCS Class I-III Angina for at least 6 months Speak, read, understand English - Exclusion Criteria: MI/Bypass last 6 months CCS Class IV angina A major cognitive disorder -

Additional Information

Official title A Psychoeducation Trial for People With Chronic Stable Angina
Principal investigator Michael H McGillion, PhD
Trial information was received from ClinicalTrials.gov and was last updated in July 2006.
Information provided to ClinicalTrials.gov by University of Toronto.